- CA$54.10m
- CA$215.26m
- CA$374.03m
- 48
- 96
- 42
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 110 | 270 | 322 | 444 | 374 |
Cost of Revenue | |||||
Gross Profit | 32.9 | 66.3 | 103 | 224 | 150 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 182 | 370 | 362 | 376 | 369 |
Operating Profit | -71.6 | -101 | -39.8 | 67.7 | 5.13 |
Net Income Before Taxes | -71.6 | -101 | -39.8 | 67.7 | 5.13 |
Provision for Income Taxes | |||||
Net Income After Taxes | -71.6 | -101 | -39.8 | 147 | 8.98 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -71.6 | -101 | -39.7 | 147 | 8.98 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -71.6 | -101 | -39.7 | 147 | 8.98 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.447 | -0.551 | -0.252 | 0.91 | 0.083 |